Newsroom

SYDNEY--(BUSINESS WIRE)--Asia Pacific’s market for technology services declined sharply in Q4, on lower demand for both cloud services and managed services: ISG Index....

DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT) announced today a time change for its fourth quarter and full year 2025 earnings conference call. The conference call will now take place at 7:30 a.m. Mountain Time (9:30 a.m. Eastern Time) on Thursday, January 29, 2026, 30 minutes earlier than previously scheduled. The Company’s financial results for the fourth quarter and full year 2025 will be released after the market closes on Wednesday, January 28, 2026, as scheduled. Individuals w...

DENVER--(BUSINESS WIRE)--Liberty Energy Inc. (NYSE: LBRT; “Liberty” or the “Company”) announced today that its Board of Directors (the “Board”) has declared a dividend of $0.09 per share of Class A common stock, to be paid on March 18, 2026, to holders of record as of March 4, 2026. Future declarations of quarterly cash dividends are subject to approval by the Board of Directors and to the Board’s continuing determination that the declarations of dividends are in the best interests of Liberty a...

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in immuno-oncology, today announced it will host its first Stakeholder Webcast of 2026, Access to Acceleration: Agenus’ Global Momentum Entering 2026 on Wednesday, January 28, 2026, at 4:00 p.m. ET. The webcast will highlight how expanding global access pathways, strategic partnerships, and operational readiness are driving momentum for Agenus’ botensilimab and balstilimab (BOT+BAL) program entering 2026. The ses...

SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, un’organizzazione di ricerca su contratto (CRO) a livello globale e impresa del gruppo JSR Life Sciences, oggi ha annunciato che il suo laboratorio di San Diego è stato accreditato dal College of American Pathologists (CAP). Questo importante traguardo si aggiunge alla certificazione CLIA (Clinical Laboratory Improvement Amendments), conseguita nel luglio 2025, rafforzando ulteriormente la capacità della struttura di fornire test sui biomarcatori di...

NEW YORK--(BUSINESS WIRE)--H.C. Wainwright & Co., LLC, announced its #1 Ranking by transaction volume for the calendar year of 2025, maintaining the Firm’s top position for 12 consecutive years, in PlacementTracker's Market League Tables, representing 144 transactions. In addition to presently serving as the #1 Investment Bank for Confidentially Marketed Public Offerings, Registered Direct, and Private Placement Offerings, H.C. Wainwright executed 345 transactions since the start of 2025 to...

CHICAGO--(BUSINESS WIRE)--Ventas, Inc. (NYSE: VTR) (the “Company”) announced today the tax treatment of its 2025 distributions on the Company’s common stock. For income tax purposes, total taxable dividend income for 2025 was $1.89 per share. This includes the Company’s fourth quarter 2024 dividend of $0.45 per share, which was declared on December 10, 2024, and was paid on January 16, 2025, to stockholders of record as of December 31, 2024. The following table summarizes the nature of these ca...

SAN DIEGO--(BUSINESS WIRE)--Crown Bioscience, een mondiale contractonderzoeksorganisatie (CRO) en een bedrijf van JSR Life Sciences, kondigde vandaag aan dat zijn laboratorium in San Diego een CAP-accreditatie (College of American Pathologists) heeft behaald. Deze mijlpaal bouwt voort op de CLIA-certificering (Clinical Laboratory Improvement Amendments) die in juli 2025 werd behaald en versterkt verder het vermogen om klinische biomarkertesten te leveren ter ondersteuning van programma's voor g...

SAN FRANCISCO--(BUSINESS WIRE)--Armis, het bedrijf voor cyberrisicobeheer en -beveiliging, heeft vandaag de bevindingen bekendgemaakt van een nieuw rapport van technologieonderzoeks- en adviesbureau Omdia. In het rapport worden de economische voordelen van Armis Centrix ™, het cyberrisicobeheerplatform van Armis, onder de loep genomen. Analisten hebben vastgesteld dat Armis wereldwijde organisaties helpt een jaarlijks rendement op investering van 351% te behalen door uitgebreid cyberrisicobehee...

SAN FRANCISCO--(BUSINESS WIRE)--Armis, le spécialiste de la gestion de la cyberexposition et de la cybersécurité, a annoncé aujourd’hui les résultats d’un nouveau rapport réalisé par la société de recherche et de conseil en technologie Omdia. Ce rapport analyse les avantages économiques d’Armis Centrix ™, la plateforme de gestion de l’exposition aux cyberrisques d’Armis. Les analystes ont constaté qu’Armis permettait aux organisations mondiales d’atteindre un retour sur investissement annuel de...